CHROMagar mSuperCARBA chromogenic media

Carbapenem-resistant Enterobacteriaceae (CRE) are usually resistant to all β-lactam agents, as well as most other classes of antimicrobial agents. The treatment options for patients infected with CRE are very limited, and healthcare-associated outbreaks of CRE have been reported. Identifying patients who are colonised with CRE, and placing these patients in isolation, may be an important step in preventing transmission.

CHROMagar has developed a highly sensitive chromogenic medium, CHROMagar mSuperCARBA, which is suitable for the detection of gram-negative bacteria with a reduced susceptibility to most of the carbapenem agents. The product can detect of a large variety of carbapenemases — including KPC, NDM, VIM, IMP and OXA — with an impressive limit of detection (10 CFU/mL) even for weakly expressed carbapenemases like OXA-48, while maintaining a high level of selectivity.